Trupanion (NASDAQ:TRUP) CFO Fawwad Qureshi Sells 6,111 Shares

Trupanion, Inc. (NASDAQ:TRUP) CFO Fawwad Qureshi sold 6,111 shares of the business’s stock in a transaction that occurred on Wednesday, August 26th. The stock was sold at an average price of $30.01, for a total value of $183,391.11. Following the sale, the chief financial officer directly owned 4,230 shares in the company, valued at $126,942.30. The trade was a 59.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Trupanion Trading Down 5.2%

Shares of NASDAQ:TRUP traded down $1.65 during trading on Wednesday, hitting $30.19. The company had a trading volume of 678,107 shares, compared to its average volume of 439,698. The stock has a market cap of $1.32 billion, a price-to-earnings ratio of 56.96, a price-to-earnings-growth ratio of 2.15 and a beta of 1.39. Trupanion, Inc. has a one year low of $21.16 and a one year high of $46.98. The company has a fifty day simple moving average of $26.63 and a two-hundred day simple moving average of $26.02. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77.

Trupanion (NASDAQ:TRUP) last released its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The firm had revenue of $392.93 million for the quarter, compared to the consensus estimate of $389.72 million. During the same quarter in the previous year, the company posted $0.22 EPS. The company’s revenue for the quarter was up 11.1% compared to the same quarter last year. As a group, equities analysts forecast that Trupanion, Inc. will post 0.63 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Atlantic Securities set a $42.00 price objective on shares of Trupanion in a research report on Wednesday, July 15th. Stifel Nicolaus upped their price target on shares of Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a report on Thursday, August 20th. Piper Sandler lowered shares of Trupanion from an “overweight” rating to a “neutral” rating and reduced their price objective for the stock from $45.00 to $32.00 in a research report on Wednesday. Zacks Research lowered Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Monday. Finally, Weiss Ratings raised Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, August 12th. One investment analyst has rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $39.20.

Institutional Trading of Trupanion

Large investors have recently made changes to their positions in the stock. Kelleher Financial Advisors purchased a new position in Trupanion in the 2nd quarter worth about $42,000. Parallel Advisors LLC boosted its position in Trupanion by 1,831.9% in the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after buying an additional 1,722 shares during the period. Kemnay Advisory Services Inc. bought a new position in Trupanion in the 4th quarter worth about $64,000. Quantbot Technologies LP bought a new position in Trupanion in the 2nd quarter worth about $89,000. Finally, Advisory Services Network LLC purchased a new position in shares of Trupanion during the third quarter worth approximately $160,000.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.